Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

3SBio Reports Higher Q2 Revenues, But Earnings Slip

publication date: Aug 13, 2008

3SBio Inc. reported that Q2 revenue increased 38% to 60 million RMB ($8.7 million), but net income actually declined 17% to 19 million RMB ($2.2 million). That number works out to earnings of 13 cents per ADS. The company took advantage of the higher sales numbers to raise its full-year 2008 revenue targets by about $4 million to a range of $34 million to $35 million. More details...

Stock Symbol: (NSDQ: SSRX)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital